Each Congress, the IgA Nephropathy Foundation advocates for federal legislation to improve treatment options, foster innovation, and increase research funding for IgAN patients and the kidney community.
Our core policy priorities center on:
- Organ Donation and Transplantation: Reducing barriers to kidney donation and streamlining the organ transplantation process.
- Health Equity and Disparities: Addressing health disparities and inequities in kidney disease treatments, with a focus on reducing disparities related to race, ethnicity, socioeconomic status, and geographic location.
- Federal Investments in Rare Kidney Disease Treatment, Innovation, and Care: Revolutionizing care for IgAN and other rare kidney diseases through investments in research and diagnostics, potential treatments, and programming.